Paper17459101
Enzymatic properties of the lactate dehydrogenase enzyme from Plasmodium falciparum.
Shoemark DK and 3 others. FEBS J, 2007. Cited by 40 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Enzymatic properties of the lactate dehydrogenase enzyme from Plasmodium falciparum. Papers, record 17459101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17459101
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| L-Lactate Dehydrogenase | Major topic |
| Plasmodium falciparum | Major topic |
| Animals | |
| Deuterium | |
| Drug Design | |
| Fluorescence Resonance Energy Transfer | |
| Hydrogen-Ion Concentration | |
| Kinetics | |
| NAD | |
| Substrate Specificity |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42783123 | Aptamer-Based Biosensors for the Detection of Malaria. | Biosensors (Basel) | 2026 | https://conductscience.org/library/papers/42783123 | PubMed |
| 40931271 | Expression, Purification and Biochemical Characterisation of Babesia bigemina Lactate Dehydrogenase. | Mol Biotechnol | 2026 | https://conductscience.org/library/papers/40931271 | PubMed |
| 40791280 | Penicillium-Derived Inhibitors of Plasmodium falciparum Lactate Dehydrogenase (PfLDH): A Computational Approach for Novel Antimalarial Therapy Development. | Scientifica (Cairo) | 2025 | https://conductscience.org/library/papers/40791280 | PubMed |
| 40160742 | Nontargeted Metabolomics of Streptomyces Sourced from Thailand Reveals the Presence of Bioactive Metabolites. | ACS Omega | 2025 | https://conductscience.org/library/papers/40160742 | PubMed |
| 39561299 | Accelerating Antimalarial Drug Discovery with a New High-Throughput Screen for Fast-Killing Compounds. | ACS Infect Dis | 2024 | https://conductscience.org/library/papers/39561299 | PubMed |
| 39162960 | Novel molecular inhibitor design for Plasmodium falciparum Lactate dehydrogenase enzyme using machine learning generated library of diverse compounds. | Mol Divers | 2024 | https://conductscience.org/library/papers/39162960 | PubMed |
| 36224571 | Antimalarial potential of compounds isolated from Mammea siamensis T. Anders. flowers: in vitro and molecular docking studies. | BMC Complement Med Ther | 2022 | https://conductscience.org/library/papers/36224571 | PubMed |
| 35672848 | A microfluidic paper analytical device using capture aptamers for the detection of PfLDH in blood matrices. | Malar J | 2022 | https://conductscience.org/library/papers/35672848 | PubMed |
| 34771034 | Purifying and Characterizing Bacterially Expressed Soluble Lactate Dehydrogenase from Plasmodium knowlesi for the Development of Anti-Malarial Drugs. | Molecules | 2021 | https://conductscience.org/library/papers/34771034 | PubMed |
| 34747601 | Structure, Function, and Thermodynamics of Lactate Dehydrogenases from Humans and the Malaria Parasite P. falciparum. | Biochemistry | 2021 | https://conductscience.org/library/papers/34747601 | PubMed |
| 33771508 | Disease variants of human Δ1-pyrroline-5-carboxylate reductase 2 (PYCR2). | Arch Biochem Biophys | 2021 | https://conductscience.org/library/papers/33771508 | PubMed |
| 33427354 | Enzyme-Loaded Nanoreactors Enable the Continuous Regeneration of Nicotinamide Adenine Dinucleotide in Artificial Metabolisms. | Angew Chem Int Ed Engl | 2021 | https://conductscience.org/library/papers/33427354 | PubMed |
| 32174721 | In vitro and in vivo analysis of the anti-plasmodial activity of ethanol extract of Phyllanthus nivosus W. Bull leaf. | J Parasit Dis | 2020 | https://conductscience.org/library/papers/32174721 | PubMed |
| 31754915 | Discovery and evaluation of inhibitory activity and mechanism of arylcoumarin derivatives on Theileria annulata enolase by in vitro and molecular docking studies. | Mol Divers | 2020 | https://conductscience.org/library/papers/31754915 | PubMed |
| 30358994 | Functional and Structural Resilience of the Active Site Loop in the Evolution of Plasmodium Lactate Dehydrogenase. | Biochemistry | 2018 | https://conductscience.org/library/papers/30358994 | PubMed |
| 28925968 | Recent Progress in the Development of Diagnostic Tests for Malaria. | Diagnostics (Basel) | 2017 | https://conductscience.org/library/papers/28925968 | PubMed |
| 28445027 | Structurally Linked Dynamics in Lactate Dehydrogenases of Evolutionarily Distinct Species. | Biochemistry | 2017 | https://conductscience.org/library/papers/28445027 | PubMed |
| 25516732 | Sequence Diversity of pfmdr1 and Sequence Conserve of pldh in Plasmodium falciparum from Indonesia: Its implications on Designing a Novel Antimalarial Drug with Less Prone to Resistance. | Iran J Parasitol | 2013 | https://conductscience.org/library/papers/25516732 | PubMed |
| 25207035 | Kinetic analysis of the amino terminal end of active site loop of lactate deyhdrogenase from Plasmodium vivax. | Balkan Med J | 2012 | https://conductscience.org/library/papers/25207035 | PubMed |
| 25125971 | Molecular and Kinetic Characterization of Babesia microti Gray Strain Lactate Dehydrogenase as a Potential Drug Target. | Drug Target Insights | 2014 | https://conductscience.org/library/papers/25125971 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17459101
GET https://conductscience.org/api/papers/v1/17459101/cited_by?page=2